Find My Journal

JG

J Growcott

AstraZeneca (United Kingdom) GB

32

Publications

538

Citations

11

H-Index

13

i10-Index

0

2yr Mean Cite

-

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Quantification of skeletal metastases in castrate‐resistant prostate cancer predicts progression‐free and overall survival OA

Campbell D. Tait, D. Moore, C. Hodgson, Michael D Brown, T. Morris - BJU International, 2014

Cited by 34 Semantic Scholar

A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients

D. Moore, A. Greystoke, Fouziah Butt, J. Wurthner, J. Growcott - Clinical drug investigation, 2012

Cited by 30 Semantic Scholar

Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer

Sarah A. Loddick, R. Bradbury, Nicola Broadbent, H. Campbell, L. Gaughan - Unknown Venue, 2012

Cited by 6 Semantic Scholar

Assessment of the variability of and effect of hormone therapy on circulating tumor cell numbers and androgen receptor expression in patients with prostate cancer.

N. Clarke, S. Marley, A. Hughes, A. Nash, M. Malone - Unknown Venue, 2012

Cited by 0 Semantic Scholar

Characterisation of endothelin-1 binding sites in colorectal cancer and antagonistic action of the endothelin a receptor antagonist zibotentan(ZD4054)

S. Haque, M. Loizidou, X. Shiwen, D. Abraham, N. Farooqui - Unknown Venue, 2011

Cited by 0 Semantic Scholar

Role of the endothelin axis and its antagonists in the treatment of cancer OA

A. Bagnato, M. Loizidou, B. Pflug, J. Curwen, J. Growcott - British Journal of Pharmacology, 2011

Cited by 116 Semantic Scholar

Abstract B107: Characterization of a small molecule selective androgen receptor downregulator: A novel approach for the treatment of castration-resistant prostate cancer.

Sarah A. Loddick, S. Brave, H. Campbell, L. Gaughan, J. Growcott - Unknown Venue, 2011

Cited by 1 Semantic Scholar

111 Endothelin A receptor antagonism with zibotentan (ZD4054) augments androgen ablation-induced inhibition of prostate tumor cell growth

B. Pflug, R. Bies, Kevin McHugh, J. Curwen, J. Growcott - Unknown Venue, 2010

Cited by 0 Semantic Scholar

161 Localisation and characterisation of ET-1 binding to human colorectal cancers and evaluation of the orally active ETA receptor antagonist zibotentan (ZD4054)

S. Haque, M. Loizidou, X. Shiwen, D. Abraham, N. Farooqui - Unknown Venue, 2010

Cited by 0 Semantic Scholar

Abstract 3890: Induction of cell cycle arrest and apoptosis in mantle cell lymphoma by AZD5438, a novel cyclin-dependent kinase inhibitor

Wann-Cheng Lo, J. Growcott, D. LeBrun, P. Greer - Unknown Venue, 2010

Cited by 0 Semantic Scholar

Research Topics

Receptor Mechanisms and Signaling (6) Neuropeptides and Animal Physiology (5) Nitric Oxide and Endothelin Effects (4) Pain Mechanisms and Treatments (4) Immune Response and Inflammation (3)

Affiliations

AstraZeneca (United Kingdom)

GB 2011 - 1980

University Dental Hospital of Manchester

GB 2004 - 2004

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers